TRPC5 and kidney disorder: Furthermore, through its ability to inhibit TRPC5, AC1903 has been demonstrated to produce in vivo therapeutic effects in different animal models of kidney disease [41], an improving effect shared by other TRPC5 inhibitors in rats [42].